Compare AU
Compare ASIA vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Asia Technology Tigers ETF (ASIA) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
ASIA | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 919 | 63 |
Median incremental investment | $881.77 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,564.64 | $1,875.72 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
ASIA | DRUG | |
|---|---|---|
Strategy | ASIA aims to track the performance of the Solactive Asia Ex-Japan Technology & Internet Tigers index. The index consists of the 50 largest technology and online retail stocks in Asia (exclusing Japan). | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | KRW - KOREAN WON (0 %) TAIWAN SEMICONDUCTOR MANUFACTU (10.45 %) TENCENT HOLDINGS LTD (9.65 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (78.07 %) Communication Services (12.32 %) Consumer Discretionary (8.85 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | China (43.17 %) Taiwan (31.14 %) Korea (13.68 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.67 % | 0.57 % |
Key Summary
ASIA | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Solactive Asia Ex-Japan Technology & Internet Tigers Index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.67 % | 0.57 % |
Price | $10.16 | $8.12 |
Size | $568.090 million | $191.120 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.53 % | 1.90 % |
Market | ASX | ASX |
First listed date | 21/09/2018 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
ASIA | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 919 | 63 |
Median incremental investment | $881.77 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,564.64 | $1,875.72 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
ASIA | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
ASIA | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |